Article By:
Benzinga
Saturday, July 3, 2021 2:29 PM EDT
Biotech stocks advanced for a second week in running, with stocks reacting to pending releases for the second quarter and the first-half of the year. The week witnessed a few COVID-19 disappointments, as well.